Jointown Pharmaceutical Group Co., Ltd (SHA: 600998)

Market Cap	26.92B
Revenue (ttm)	149.20B
Net Income (ttm)	2.05B
Shares Out	4.91B
EPS (ttm)	0.41
PE Ratio	13.50
Forward PE	11.99
Dividend	0.19 (3.51%)
Ex-Dividend Date	Jun 7, 2024

Volume	41,398,429
Open	5.37
Previous Close	5.37
Day's Range	5.32 - 5.55
52-Week Range	4.35 - 8.95
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Jointown Pharmaceutical Group

Jointown Pharmaceutical Group Co., Ltd provides pharmaceutical supply chain services in China. It is also involved in general agency brand promotion; digital retail; intelligent logistics and supply chain solutions; and medical health and technology value-added service businesses. In addition, the company manufactures western medicines, such as antibiotics, anti-diabetic drugs, and cardiovascular drugs; and other OEM medicines. The company was founded in 1999 and is based in Wuhan, China.

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1999
• Employees: 30,100
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600998

Financial Performance

In 2023, Jointown Pharmaceutical Group's revenue was 150.14 billion, an increase of 6.92% compared to the previous year's 140.42 billion. Earnings were 2.17 billion, an increase of 4.27%.